US1 faces funding pressure if its US$1 million licence payment is delayed

Cash runway falls to 0.16 quarters

US1 Critical Minerals Limited (ASX:USC) finished the September quarter with just A$65,000 in cash after using A$406,000 in operating activities. The company’s own Appendix 5B calculation puts its available funding at 0.16 quarters, assuming its current level of net operating cash flow continues.

The cash position is particularly stark because no financing proceeds were recorded during the quarter. US1 spent A$175,000 on exploration and evaluation, A$107,000 on staff costs and A$125,000 on administration and corporate costs, partly offset by A$168,000 in proceeds from the disposal of tenements and A$1,000 of interest received.

US1 says it expects to remain in the development and pre-revenue stage and acknowledges that its current operating cash flows are expected to continue for the time being. The company points to the proposed Tanzanian licence transfer, cash on hand and ongoing discussions with key shareholders as the basis for continuing operations. It also says it has capacity to issue 69 million shares under ASX Listing Rule 7.1 and a further 96 million under Rule 7.1A.

Tanzanian uranium sale remains the key funding catalyst

The proposed transfer of six uranium licences covering the Mkuju, Foxy and Eland projects to London AIM-listed Bradda Head Lithium remains the most immediate potential source of liquidity. The deal, first reported as a conditional Tanzanian licence sale, would provide US$1 million in cash on completion, with a further US$300,000 tied to confirmation of an indicated or measured uranium resource of at least 25 million pounds of U3O8 and US$500,000 linked to a definitive feasibility study and a formal decision to build a mine.

Those additional payments are contingent rather than near-term funding. The transaction still requires customary closing conditions, including applicable Tanzanian regulatory approvals, although US1 says these are presently anticipated to be met in the near term. Bradda Head is also required to undertake preliminary exploration within 12 months of completion.

US1 will retain its 100% interest in the Lilombe rare earths project and is evaluating more detailed geological mapping there. No mining production or development activity occurred during the quarter, leaving the company reliant on completing the licence transaction or securing additional funding before its stated cash horizon expires.

Legal disputes continue alongside asset reshaping

In California, US1 and Apex USA Resources remain before the Federal Court in a dispute involving rare earths tenements identified under their agreement. The court has reserved judgment, while Dateline Resources, its subsidiaries and Stephen Baghdadi have undertaken not to encumber, sell, transfer or otherwise disturb the status quo of the relevant tenements without 14 days’ notice to US1 and Apex or further court order.

The company also continued pre-trial work in its Federal Court case against Andrew John Price. US1 alleges that statements made on X since late 2023 were false, malicious and misleading, and says they prevented it from pursuing commercial and business opportunities. The company is seeking damages, but the filing provides no indication of timing or likely outcome.

Option grant adds a potential dilution question

During the quarter, US1 granted 25 million options to Emes Corporate LLC for consultancy services covering business development, introductions, negotiations, project evaluation and transaction support. The options are exercisable at A$0.02 and expire on 31 May 2029, matching the fixed term of the consultancy contract.

The grant follows earlier disclosures involving Emes and adds another potential source of dilution to a company already considering its liquidity options. US1 also reported A$81,000 in related-party payments during the quarter, comprising director fees and superannuation.